McMillan Shakespeare Ltd (ASX: MMS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

McMillan Shakespeare Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $765.30 million
P/E Ratio 11.71
Dividend Yield 6.59%
Shares Outstanding 77.38 million
Earnings per share 0.844
Dividend per share 0.68
Year To Date Return -15.40%
Earnings Yield 8.54%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

McMillan Shakespeare Ltd (ASX: MMS)
Latest News

Man in business suit above the clouds plummeting downwards back first
Share Fallers

McMillan Shakespeare (ASX:MMS) share price plummets 9% despite 2500% rise in NPAT

Investors may be asking themselves, "To own, or not to own? That is the question."

Read more »

ASX share price slide represented by investor slipping on banana skin
Share Market News

Why the McMillan Shakespeare (ASX:MMS) share price has slipped today

The McMillan Shakespeare (ASX MMS) share price has slipped 2.46% following the release of its half-year results. Here's the low…

Read more »

Share investor with chess pieces deciding to buy or sell ASX shares
⏸️ ASX Shares

3 top ASX shares to buy according to WAM

The 3 ASX shares in this article are rated as buys according to WAM, including McMillan Shakespeare Limited (ASX: MMS).

Read more »

asx share price represented by cartoon of man driving along rising arrow in a car ASX stocks
Cheap Shares

3 forgotten ASX stocks left behind in the car sales recovery

ASX auto stocks have zoomed ahead of the market in the COVID-19 recovery trade but there’s one group that’s been…

Read more »

close up of man's eye looking through magnifying glass representing asx 200 share price on watch
Share Market News

McMillan (ASX:MMS) share price on watch today. Here’s why

The McMillan (ASX: MMS) share price will be on watch today following a business update and preliminary result for the…

Read more »

ASX share price broker upgrade ASX lithium shares buy represented by upgrade button on computer keyboard
Cheap Shares

Top brokers just upgraded the ResMed (ASX:RMD) share price and this other ASX stock

Leading brokers just upgraded two ASX stocks to their buy list even as we enter what could be the most…

Read more »

agm causing asx share price rise represented by letter blocks spelling agm on top of coin piles
Share Market News

McMillan (ASX:MMS) share price edges up on AGM

The McMillan share price is up 3.08% today after the company's positive Q1 results in its AGM. Revenues were reported…

Read more »

A graph ablaze with fire going up, indicating a fired up and surged share price
Share Market News

ASX 200 jumps 2.6%, big 4 banks surge

The S&P/ASX 200 Index (ASX:XJO) soared 2.6%, the Mesoblast Limited (ASX:MSB) share price jumped 11.6% after last week’s decline.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
10 Mar 2022 $0.3400 100.00% Interim 25 Mar 2022
09 Sep 2021 $0.3110 100.00% Final 24 Sep 2021
11 Mar 2021 $0.3020 100.00% Interim 26 Mar 2021
05 Mar 2020 $0.3400 100.00% Interim 20 Mar 2020
28 Aug 2019 $0.4000 100.00% Final 11 Sep 2019
07 Mar 2019 $0.3400 100.00% Interim 22 Mar 2019
13 Sep 2018 $0.4000 100.00% Final 28 Sep 2018
15 Mar 2018 $0.3300 100.00% Interim 29 Mar 2018
28 Sep 2017 $0.3500 100.00% Final 13 Oct 2017
30 Mar 2017 $0.3100 100.00% Interim 13 Apr 2017
29 Sep 2016 $0.3400 100.00% Final 14 Oct 2016
31 Mar 2016 $0.2900 100.00% Interim 15 Apr 2016
29 Sep 2015 $0.2700 100.00% 16 Oct 2015
30 Mar 2015 $0.2500 100.00% 17 Apr 2015
29 Sep 2014 $0.3100 100.00% 15 Oct 2014
16 Sep 2010 $0.1400 100.00% Final 15 Oct 2010

MMS ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About McMillan Shakespeare Ltd

McMillan Shakespeare Limited (ASX: MMS) is a market leader in salary packaging, novated leasing, and fleet and asset management services. McMillan provides services to major employers across Australia, New Zealand and the United Kingdom through brands including Maxxia, RemServ, Interleasing and Holden Leasing.

Clients include state and federal governments, hospitals, not-for-profit organisations and private corporations.

From its origins in 1988 when McMillan first pioneered Australia’s salary packaging industry, the company has grown into a global organisation and top 200 ASX-listed company. With more than 1,200 staff, offices and representatives in every Australian state and territory, as well as Auckland and London, McMillan manages more than 290,000 employee benefit programs and more than 70,000 vehicles.

The McMillan share price has been impacted in FY20 as the COVID-19 pandemic sent a wrecking ball through Australia’s workforce. However, the professional services firm is gaining traction with its rapid digital program expansion to service customers remotely.

MMS Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Jul 2022 $9.88 $-0.17 -1.69% 138,180 $10.09 $10.18 $9.80
04 Jul 2022 $10.05 $0.31 3.18% 121,021 $9.84 $10.33 $9.84
01 Jul 2022 $9.74 $0.00 0.00% 69,964 $9.88 $9.94 $9.74
30 Jun 2022 $9.74 $0.10 1.04% 218,279 $9.64 $9.84 $9.63
29 Jun 2022 $9.64 $-0.10 -1.03% 172,407 $9.64 $9.69 $9.48
28 Jun 2022 $9.74 $-0.05 -0.51% 126,494 $9.73 $9.91 $9.66
27 Jun 2022 $9.79 $0.19 1.98% 191,813 $9.76 $9.90 $9.50
24 Jun 2022 $9.60 $0.30 3.23% 201,493 $9.31 $10.04 $9.28
23 Jun 2022 $9.30 $0.23 2.54% 639,837 $9.18 $9.50 $9.09
22 Jun 2022 $9.07 $-0.32 -3.41% 147,865 $9.43 $9.59 $8.94
21 Jun 2022 $9.39 $0.38 4.22% 200,212 $9.10 $9.39 $9.07
20 Jun 2022 $9.01 $-0.23 -2.49% 126,150 $9.30 $9.32 $8.89
17 Jun 2022 $9.24 $-0.15 -1.60% 308,624 $9.32 $9.39 $9.03
16 Jun 2022 $9.39 $-0.35 -3.59% 216,303 $9.75 $9.82 $9.35
15 Jun 2022 $9.74 $-0.12 -1.22% 180,633 $9.95 $9.95 $9.68
14 Jun 2022 $9.86 $-0.39 -3.80% 329,352 $10.05 $10.15 $9.67
10 Jun 2022 $10.25 $-0.01 -0.10% 178,173 $10.38 $10.38 $10.02
09 Jun 2022 $10.26 $-0.31 -2.93% 295,727 $10.57 $10.57 $10.11
08 Jun 2022 $10.57 $-0.45 -4.08% 126,334 $11.00 $11.05 $10.45
07 Jun 2022 $11.02 $-0.39 -3.42% 96,123 $11.47 $11.47 $10.96

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
30 Nov 2021 Michael (Mike) Salisbury Issued 71 $898,072
Issue of securities. As per announcement on 01/12/2021
203,165 - Performance Rights & Indeterminate Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Timothy Michael Poole Non-Executive Director Dec 2013
Mr Poole is currently Chair of Aurizon Holdings Limited and a Non-Executive Director of Reece Limited. Mr Poole was previously an executive of the unlisted infrastructure and private equity manager, Hastings Funds Management (1995 to 2007), including being the Managing Director from 2005. He was formerly the Non-Executive Chair of Lifestyle Communities Limited. He is member of people, culture, risk & compliance committee.

Mr Bruce John Akhurst Non-Executive Director Apr 2021
Mr Akhurst is currently Non-Executive Director, Chair of the Risk and Compliance Committee and a member of the People and Remuneration Committee and Technology Committee at Tabcorp Holdings Limited. Mr Akhurst is also Chair of the Peter McCallum Cancer Foundation and Council Member of RMIT University chairing the Technology and Infrastructure Committee. He was previously Non-Executive Director and a member of the People, Culture and Remuneration Committee of Vocus Group Limited, CEO of Sensis, Group MD and General Counsel of Telstra and a Partner of Mallesons Stephen Jaques. He is Member of risk & Compliance committee and chairperson of people and culture committee.
Mr John G Bennetts Non-Executive Director Dec 2003
Mr Bennetts is an experienced investor and has been the founder and director of a number of successful Australian companies. He owns businesses in varied industries including technology and finance. He is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia. Prior to the establishment of M-Group, he was a senior executive of pioneering Australian multinational IT company, Datacraft Limited and also practised as a commercial lawyer. He is member of risk & compliance committee.
Mr Ross Chessari Non-Executive Director Dec 2003
Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
Ms Helen Kurincic Non-Executive DirectorNon-Executive Chairman Sep 2018
Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its earliest inception, creating and developing the first and largest radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. She is member of people, culture, risk & compliance committee.
Mr Robert (Rob) De Luca Chief Executive OfficerManaging Director May 2022
Mr De Luca is a CEO with over 20 years' experience in banking, financial services, wealth management, and disability. Over that period, he has led and grown organizations through periods of technological, economic and regulatory change. Mr De Luca was formerly CEO of Zenitas Healthcare, CEO of the National Disability Insurance Agency and Managing Director of Bankwest. Prior to that he was at CBA in roles including Executive General Manager Retail & Business Banking, Executive General Manager Corporate Financial Services, CEO ASB Group Investments (NZ), Executive General Manager Wealth Management and Executive Manager E-Commerce Strategy & Ventures. He started his career as a Credit Analyst at NAB.
Ms Kathryn Maree Parsons Non-Executive Director May 2020
Ms Parsons is a former audit partner at Ernst & Young where she spent time as a partner in the firm's US, UK and Australian practices. In addition to her audit client responsibilities she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She is member of people and culture committee and chairperson of risk & compliance committee.
Mr Ashley Conn Chief Financial OfficerCompany Secretary Oct 2020
-
Ashley Conn Chief Financial OfficerCompany Secretary
-
G Kruyt Chief Operating Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Aust) Ltd 28,227,083 36.48%
J P Morgan Nominees Australia Pty Limited 9,859,180 12.74%
Citicorp Nominees Limited 7,633,731 9.87%
Chessari Holdings Pty Limited 6,050,941 7.82%
Asia Pac Technology Pty Ltd 3,068,025 3.96%
CS Third Nominees Pty Limited <Hsbc Cust Nom Au Ltd 13 A/C> 2,457,774 3.18%
UBS Nominees Pty Ltd 2,132,982 2.76%
National Nominees Limited 1,943,961 2.51%
Ann Leslie Ryan 1,008,418 1.30%
BNP Paribas Noms Pty Ltd <Drp> 999,993 1.29%
Milton Corporate Limited 803,532 1.04%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 723,575 0.94%
MOHL Invest Pty Ltd <MOHL Super Fund A/C> 590,000 0.76%
Afico Pty Ltd 495,625 0.64%
NWC Group Pty Ltd 437,781 0.57%
Mr Kenneth Joseph Hall <Hall Park A/C) 250,000 0.32%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> 190,375 0.25%
HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 134,341 0.17%
BNP Paribas Nominees Pty Ltd <Ioof Instmt Mgt Ltd Drp> 131,169 0.17%
MOD Enterprises Pty Ltd 129,619 0.17%

Profile

since

Note